Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 506 | 554 | 152 | 1,845 | 9,216 |
| Marketable Securities | N/A | 163 | 178 | 135 | 234 |
| Receivables | 183 | 218 | 201 | 216 | 144 |
| Other current assets | 427 | 486 | 407 | 970 | 1,045 |
| TOTAL | $1,214 | $1,669 | $1,439 | $4,147 | $13,328 |
| Non-Current Assets | |||||
| PPE Net | 106 | 185 | 202 | 202 | 119 |
| Intangibles | 10,507 | 10,621 | 10,734 | 10,848 | 78,548 |
| Other Non-Current Assets | 922 | 1,069 | 1,135 | 5,972 | 6,041 |
| TOTAL | $11,536 | $11,874 | $12,071 | $17,022 | $84,708 |
| Total Assets | $12,749 | $13,542 | $13,510 | $21,170 | $98,036 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,442 | 11,678 | 8,292 | 5,716 | 5,929 |
| Other current liabilities | 682 | 681 | 326 | 326 | 671 |
| TOTAL | $22,231 | $19,670 | $15,073 | $11,245 | $10,187 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 10,625 | 12,917 |
| Deferred Revenues | 387 | 550 | 206 | 374 | 506 |
| Other Non-Current Liabilities | 694 | 797 | 874 | 817 | 751 |
| TOTAL | $686 | $793 | $871 | $11,431 | $13,654 |
| Total Liabilities | $22,917 | $20,464 | $15,945 | $22,677 | $23,841 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,662 | 53,296 | 50,745 | 51,141 | 32,096 |
| Common Shares | 254 | 248 | 250 | 177 | 161 |
| Retained earnings | -144,076 | -140,727 | -137,239 | -129,482 | -52,256 |
| Other shareholders' equity | 127 | 93 | 26 | 55 | 70 |
| TOTAL | $-10,168 | $-6,921 | $-2,435 | $-1,507 | $74,195 |
| Total Liabilities And Equity | $12,749 | $13,542 | $13,510 | $21,170 | $98,036 |